Iron Horse Acquisitions Corp. Reports Director and Officer Changes

TL;DR

Iron Horse Acquisitions Corp. (IROH) filed an 8-K detailing board and executive changes.

AI Summary

Iron Horse Acquisitions Corp. filed an 8-K on October 25, 2024, reporting changes in its board of directors and executive officers, as well as updates to compensatory arrangements. The filing details the election of new directors and the appointment of certain officers, alongside information regarding their compensation.

Why It Matters

Changes in a company's leadership and compensation structures can signal shifts in strategy or governance, impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — This filing primarily concerns corporate governance and executive appointments, which typically carry a low direct financial risk.

Key Players & Entities

• Iron Horse Acquisitions Corp. (company) — Registrant
• October 25, 2024 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of Incorporation
• 001-41898 (sec_file_number) — SEC File Number

FAQ

Key Financial Figures

• $11.50 — of common stock at an exercise price of $11.50 per share IROHW The Nasdaq Stock Ma

Filing Documents

• ea0218852-8k_ironhor.htm (8-K) — 36KB
• 0001213900-24-091267.txt ( ) — 266KB
• iroh-20241025.xsd (EX-101.SCH) — 4KB
• iroh-20241025_def.xml (EX-101.DEF) — 27KB
• iroh-20241025_lab.xml (EX-101.LAB) — 38KB
• iroh-20241025_pre.xml (EX-101.PRE) — 26KB
• ea0218852-8k_ironhor_htm.xml (XML) — 8KB

02 Departure of Directors or Certain Officers; Election of

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 25, 2024, Iron Horse Acquisitions Corp. (the "Company") received the resignation of Ms. Jane Waxman as Chief Financial Officer of the Company effective immediately. Ms. Waxman's resignation was due to personal reasons and was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. Ms. Waxman will continue to serve as a director of the Company. On the same date, the Company's current Chief Operating Officer, William Caragol, was appointed as the Company's Chief Financial Officer by the Company's board of directors. No family relationships exist between Mr. Caragol and any of the Company's directors or other executive officers. There is no arrangement or understanding between Mr. Caragol and any other persons pursuant to which he was selected as the Chief Financial Officer, and there are no related party transactions involving Mr. Caragol that are reportable under Item 404(a) of Regulation S-K. William Caragol has been the Chief Operating Officer of the Company since the Company's inception. He has over thirty years of experience working with growth stage companies. In 2018, he founded and is the Managing Director of Quidem LLC, a corporate strategic and financial advisory firm. Since July 2021 he has been the Chief Financial Officer of Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer. Since 2015, Mr. Caragol has been Chairman of the Board of Thermomedics, Inc., a privately held medical diagnostic equipment company. Since July 2021, Mr. Caragol has served on the Board of Directors of Worksport Ltd. (NASDAQ: WKSP), a growth stage technology company. Since July 2023, Mr. Caragol has served on the Board of Directors of Janover, Inc. (NASDAQ: JNVR), a B2B fintech

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these

forward-looking statements can be identified by the use of words such as "believes," "expects," "intends,"

forward-looking statements can be identified by the use of words such as "believes," "expects," "intends," "plans," "estimates," "assumes," "may," "should," "will," "seeks," or other similar expressions. Such statements may include, but are not limited to, statements regarding the impact of the Company's restatement of certain historical financial statements, the Company's cash position and cash held in the Trust Account and any proposed remediation measures with respect to identified material weaknesses. These statements are based on current expectations on the date of this Current Report on Form 8-K and involve a number of risks and uncertainties that may cause actual results to differ significantly. The Company does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements. 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 28, 2024 IRON HORSE ACQUISITIONS CORP. By: /s/ Jose Antonio Bengochea Name: Jose Antonio Bengochea Title: Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR